Article
A rapid and ultrasensitive CRISPR-Cas12a assay for clinical detection of pathogens and mutations.
Analytical and bioanalytical chemistry - 1 Apr 2026
Fu Tao, Zhao Dongdong, Wang Qin, Peng Nanyue, Zhang Le, Chen Siqi, Ren Jiangbin, Tang Fan, Pu Ke, Wu Qiaoli, Bi Changhao, Zhang Xueli, Li Qingguo
Abstract excerpt
CRISPR-Cas12a-driven nucleic acid diagnostics offer considerable potential for highly specific and rapid detection. However, their practical applications are limited by the necessity for pre-amplification of target DNA to enhance sensitivity. To overcome this limitation, we developed Auto-catalys...
Topics
- Humans
- CRISPR-Cas Systems
- Isocitrate Dehydrogenase
- Mutation
- Limit of Detection
- Glioma
- Rapid Diagnostic Tests
- Brain Neoplasms
- Nucleic Acid Amplification Techniques
- Bacterial Proteins
- Endodeoxyribonucleases
- CRISPR-Associated Proteins
